Inventor · disambiguated record
David Campbell
Also filed as: CAMPBELL DAVID · CAMPBELL DAVID A · CAMPBELL DAVID ALAN
37 granted patents·25 pending applications·1,249 citations·filing 1992–2024
98Inventor score
Top patents by PatentIndex Score
62 records- 0198US5362899AChiral synthesis of alpha-aminophosponic acidsAFFYMAX TECH NV·Filed 1993·Granted Nov 8, 1994·167 cites·16 claims
- 0296US5932579ACollagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1996·Granted Aug 3, 1999·97 cites·13 claims
- 0395US5359115AMethods for the synthesis of phosphonate estersAFFYMAX TECH NV·Filed 1992·Granted Oct 25, 1994·172 cites·11 claims
- 0494US7825139B2Compounds and methods for selective inhibition of dipeptidyl peptidase-IVFOREST LAB HOLDINGS LTD BM·Filed 2006·Granted Nov 2, 2010·31 cites·18 claims
- 0594US5817751AMethod for synthesis of diketopiperazine and diketomorpholine derivativesAFFYMAX TECH NV·Filed 1996·Granted Oct 6, 1998·147 cites·9 claims
- 0692US11548892B1Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2022·Granted Jan 10, 2023·4 cites·6 claims
- 0792US7576121B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Aug 18, 2009·15 cites·56 claims
- 0892US7317109B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Jan 8, 2008·21 cites·27 claims
- 0992US6083682ASystem and method for solid-phase parallel synthesis of a combinatorial collection of compoundsGLAXO GROUP LTD·Filed 1997·Granted Jul 4, 2000·100 cites·28 claims
- 1091US6168914B1System and method for solid-phase parallel synthesis of a combinatorial collection of compoundsGLAXO WELLCOME INC·Filed 1998·Granted Jan 2, 2001·117 cites·23 claims
- 1191US5420328AMethods for the synthesis of phosphonate estersAFFYMAX TECH NV·Filed 1993·Granted May 30, 1995·103 cites·11 claims
- 1290US5990112AInhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1996·Granted Nov 23, 1999·73 cites·5 claims
- 1389US7674913B2Heterocyclic boronic acid compoundsPHENOMIX CORP·Filed 2004·Granted Mar 9, 2010·27 cites·7 claims
- 1488US5840698AInhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1995·Granted Nov 24, 1998·37 cites·14 claims
- 1580US7884217B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2007·Granted Feb 8, 2011·3 cites·4 claims
- 1679US8674095B2Compounds for treating neuropsychiatric conditionsCAMPBELL DAVID·Filed 2009·Granted Mar 18, 2014·4 cites·7 claims
- 1778US7767828B2Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2006·Granted Aug 3, 2010·3 cites·31 claims
- 1878US5302707A5-fluorouridine nucleoside phosphate compoundsAFFYMAX TECH NV·Filed 1992·Granted Apr 12, 1994·19 cites·8 claims
- 1978US2025011324A1Transglutaminase 2 (tg2) inhibitorsSITARI PHARMA INC·Filed 2024·Application pending·0 cites
- 2077US8372970B28-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersAFRAXIS INC·Filed 2010·Granted Feb 12, 2013·4 cites·15 claims
- 2177US7906658B2Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IVPHENOMIX CORP·Filed 2007·Granted Mar 15, 2011·2 cites·9 claims
- 2276US8680099B26-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Mar 25, 2014·2 cites·55 claims
- 2376US5929278AInhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1998·Granted Jul 27, 1999·12 cites·8 claims
- 2475US8912203B26-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disordersCAMPBELL DAVID·Filed 2011·Granted Dec 16, 2014·1 cites·32 claims
- 2573US7786163B2Constrained cyano compoundsFOREST LAB HOLDINGS LTD BM·Filed 2005·Granted Aug 31, 2010·2 cites·34 claims
- 2671US7365178B2Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysisACTIVX BIOSCIENCES INC·Filed 2004·Granted Apr 29, 2008·7 cites·28 claims
- 2770US6307101B1Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useFiled 1999·Granted Oct 23, 2001·9 cites·4 claims
- 2869US8415295B2Heterocyclic boronic acid compoundsCAMPBELL DAVID ALAN·Filed 2010·Granted Apr 9, 2013·2 cites·12 claims
- 2967US5831004AInhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1995·Granted Nov 3, 1998·13 cites·8 claims
- 3064US12152026B2Transglutaminase 2 (TG2) inhibitorsSITARI PHARMA INC·Filed 2019·Granted Nov 26, 2024·0 cites·27 claims
- 3162US6598905B2Hose couplingVISTEON GLOBAL TECH INC·Filed 2000·Granted Jul 29, 2003·14 cites·25 claims
- 3255US6271232B1Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1999·Granted Aug 7, 2001·5 cites·14 claims
- 3355US2007185061A1Heterocyclic boronic acid compoundsCAMPBELL DAVID A·Filed 2006·Application pending·0 cites
- 3454US5816626ASpring lock couplingFORD MOTOR CO·Filed 1995·Granted Oct 6, 1998·22 cites·9 claims
- 3553US2014364430A1Methods for treating schizophreniaAFRAXIS HOLDINGS INC·Filed 2014·Application pending·0 cites
- 3650US2012184547A1Methods for treating schizophreniaLICHTER JAY·Filed 2010·Application pending·0 cites
- 3749US2015031693A1Pak inhibitors for the treatment of fragile x syndromeAFRAXIS HOLDINGS INC·Filed 2012·Application pending·0 cites
- 3848US2010323953A1Macrocyclic hepatitis c protease inhibitorsPHENOMIX CORP·Filed 2008·Application pending·0 cites
- 3947US7786312B2Methods of preparing heterocyclic boronic acids and derivatives thereofPHENOMIX CORP·Filed 2006·Granted Aug 31, 2010·0 cites·41 claims
- 4047US5874589AMethods for synthesizing diverse collections of tetramic acids and derivatives thereofGLAXO WELLCOME INC·Filed 1997·Granted Feb 23, 1999·3 cites·7 claims
- 4147US2013116263A1Pak inhibitors for the treatment of cell proliferative disordersAFRAXIS INC·Filed 2012·Application pending·0 cites
- 4246US2013225575A1Methods for treating neurological conditionsLICHTER JAY·Filed 2011·Application pending·0 cites
- 4346US2006135553A1Imidazole derivativesCAMPBELL DAVID A·Filed 2005·Application pending·0 cites
- 4445US2014323478A1Serine/threonine kinase inhibitorsAFRAXIS HOLDINGS INC·Filed 2014·Application pending·0 cites
- 4545US2013338153A18-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disordersCAMPBELL DAVID·Filed 2011·Application pending·0 cites
- 4645US2010120716A1Macrocyclic hepatitis c serine protease inhibitors and uses thereforPHENOMIX CORP·Filed 2007·Application pending·0 cites
- 4743US7923433B2Activity-based probes and methods of their preparation and useACTIVX BIOSCIENCES INC·Filed 2003·Granted Apr 12, 2011·0 cites·13 claims
- 4841US2013158043A1Pak inhibitors for the treatment of cancerAFRAXIS INC·Filed 2012·Application pending·0 cites
- 4941US2010087658A1Methods and intermediates for synthesis of selective dpp-iv inhibitorsPHENOMIX CORP·Filed 2008·Application pending·0 cites
- 5040US2009304631A1Hepatitis c serine protease inhibitors and uses thereforCAMPBELL DAVID ALAN·Filed 2007·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →